Primary study · included by 1 review

Long-Term Outcome Following Treatment With Allogeneic Mesenchymal Stem/Stromal Cells for Radiation-Induced Hyposalivation and Xerostomia.

Jakobsen 2024 (MESRIX-II 12-month follow-up) · Jakobsen Kathrine Kronberg, Lynggaard Charlotte Duch, Paaske Natasja, et al. · Stem cells translational medicine · 2024

Included by

Treatment of Xerostomia with Mesenchymal Stem Cells - A Systematic Review and Meta-Analysis of Clinical Trials.

Non-Cochrane · intervention · 2026 · cited as Jakobsen 2024 (MESRIX-II 12-month follow-up) · Results, Table 1; reference 35

The review does not say which of its outcomes this study informs.

1 including review in total.